Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
01 5Mission | CDMO
02 1Polfa Tarchomin
03 6Strides Pharma Science
04 2ANI Pharmaceuticals Inc
05 1Acarpia Farmaceutici
06 3Ajanta Pharma Limited
07 2Alliance Pharmaceutical Company
08 3Ascent Innovative Medicines
09 2Bionpharma
10 3HIBROW HLTHCARE
11 1Meda AB
12 1Recordati
13 2Rising Pharmaceuticals Inc
14 1SIGMA TAU
15 3Teva Pharmaceutical Industries
16 3Torrent Pharmaceuticals Limited
17 2UT Southwestern Medical Center
18 1Vital Pharma Nordic ApS
19 1West-Coast Pharmaceuticals
20 3Zydus Pharmaceuticals
01 1Extended Release Tablet
02 3Extended-Release Tablet
03 2FOR SOLUTION;ORAL
04 1Granules
05 1ORAL SOLUTION
06 2SUS
07 2TABLET (EXTENDED-RELEASE)
08 27TABLET, EXTENDED RELEASE;ORAL
09 5Tablet
10 1Tablet with modified release
11 1Blank
01 5DISCN
02 1Dossier Available
03 2Generic
04 2Prescription
05 24RX
06 12Blank
01 1Alkacite
02 1Biochetasi
03 2Gencit Simplex
04 1Kajos
05 26POTASSIUM CITRATE
06 1Potassion
07 5UROCIT-K
08 1Urocit
09 8Blank
01 2Canada
02 7India
03 2Italy
04 1Norway
05 1Poland
06 2South Africa
07 1Sweden
08 1Switzerland
09 29USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 1985-08-30
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Tablet
Dosage Strength : 1080MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 1992-08-31
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2009-12-30
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : UROCIT-K
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 540MG
Packaging : 100
Approval Date :
Application Number : 1914022
Regulatory Info : Prescription
Registration Country : Canada
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : UROCIT-K
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 1080MG
Packaging : 100
Approval Date :
Application Number : 2353997
Regulatory Info : Prescription
Registration Country : Canada
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Extended-Release Tablet
Dosage Strength : 5MEQ
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Extended-Release Tablet
Dosage Strength : 10MEQ
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Extended-Release Tablet
Dosage Strength : 15MEQ
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2021-02-05
Application Number : 214420
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2020-01-14
Application Number : 212779
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2020-01-14
Application Number : 212779
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2020-06-29
Application Number : 212799
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2020-06-29
Application Number : 212799
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2006-06-09
Application Number : 77440
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2006-06-09
Application Number : 77440
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2024-02-06
Application Number : 213986
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2024-02-06
Application Number : 213986
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2024-02-06
Application Number : 213986
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-10-13
Application Number : 19647
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 10MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-10-13
Application Number : 19647
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?
